Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 18

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 18
---
 continue to offer our securities to investors; and (iii) may cause the value of such securities to significantly decline or be worthless. Investing in Living Homeopathy’s Class A Ordinary Shares involves significant risks. You should carefully consider all of the information in this prospectus before making an investment in the Class A Ordinary Shares. Below please find a summary of the principal risks we face, organized under relevant headings. These risks are discussed in more detail in the section titled “ Risk Factors” beginning on page 17 of this prospectus. Risks Related to Our Business Risks and uncertainties related to our business and industry include, but are not limited to, the following:

| ● | We                                                                                           
 operate in a competitive and rapidly evolving industry; it may be difficult to evaluate our  
 prospects, and we may not be able to effectively manage our growth or implement our business 
 growth plan. See more detailed discussion of this risk factor on page 17 of this prospectus. |

| ● | Unfavorable                                                                                 
 publicity or consumer acceptance of our products generally could reduce our sales. See more 
 detailed discussion of this risk factor on page 17 of this prospectus.                      |

| ● | Our                                                                                           
 business   is heavily regulated and our industry may be subject to increasingly tightened     
 regulatory requirements and scrutiny in the main markets where we operate and the new markets 
 we will sell our products, which could potentially adversely affect our business growth,      
 financial condition and results of operations.  See more detailed discussion of this          
 risk factor on page 18 of this prospectus.                                                    |

| ● | Potential                                                                                        
 product liability, false marketing or other consumer claims against us could cause us to         
 incur substantial liabilities and we may face regulatory penalties. See more detailed discussion 
 of this risk factor on page 19 of this prospectus.                                               |

| ● | We                                                                                         
 may be subject to enforcement action if we, our employees or mentors and mentees engage in 
 improper marketing or promotion of our products. See more detailed discussion of this risk 
 factor on page 19 of this prospectus.                                                      |

| ● | The                                                                                          
 sustainability of our mentor and mentee program relies on mentors and mentees’ strict        
 compliance with, and our effective enforcement of, our written marketing manual governing    
 the mentor and mentee’s rights and obligations, qualification and other, as well as          
 compliance with the relevant laws and regulations. See more detailed discussion of this risk 
 factor on page 20 of this prospectus.                                                        |

| ● | If                                                                                                
 the